J.P. Morgan discloses Kangji Medical share dealings amid privatization

J.P. Morgan Securities PLC, an associate connected with the Offeror, disclosed its dealings in Kangji Medical Holdings Limited shares on September 8, 2025, in connection with the company's privatization by way of scheme of arrangement. These dealings were executed for J.P. Morgan's own account and involved hedging Delta 1 products from wholly unsolicited client-driven orders.

The disclosure shows J.P. Morgan Securities PLC made both sales and purchases. A sale of 500 shares was recorded at a total of $4,404.18, with both the highest and lowest prices paid/received at $8.82.

In terms of purchases, J.P. Morgan acquired 4,500 shares for $39,692.33 and an additional 77,000 shares for $678,674.40. For all purchase transactions, the highest and lowest prices paid/received were consistently $8.81. J.P. Morgan Securities PLC is ultimately owned by JPMorgan Chase & Co.